Literature DB >> 990974

Experiences with physostigmine in the reversal of adverse post-anaesthetic effects.

J Brebner, L Hadley.   

Abstract

Physostigmine salicylate has proved to be a very useful agent for use in the recovery room. All but two of our first 110 patients receiving it were returned to full consciousness, whether they had been comatose or agitated. In our hands it has been used to reverse the adverse central effects of tranquilizers, antihistamines and belladonna alkaloids.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 990974     DOI： 10.1007/bf03006738

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN： 0008-2856


  19 in total

1.  Editorial: Physostigmine: value in treatment of central toxic effects of anti-cholinergic drugs.

Authors:  H H Hussey
Journal:  JAMA       Date:  1975-03-10       Impact factor: 56.272

2.  Reversal of datura stramonium delirium with physostigmine: report of three cases.

Authors:  R Orr
Journal:  Anesth Analg       Date:  1975 Jan-Feb       Impact factor: 5.108

3.  ALTERATIONS IN THE ACTIVITY OF PENTOTHAL, PHENOBARBITAL, PENTYLENETETRAZOL, AND STRYCHNINE BY CHOLINESTERASE INHIBITORS.

Authors:  V A GREEN
Journal:  J Pharm Sci       Date:  1964-07       Impact factor: 3.534

4.  Reversal of amitriptyline intoxication by physostigmine.

Authors:  B D Snyder; L Blonde; W R McWhirter
Journal:  JAMA       Date:  1974-12-04       Impact factor: 56.272

5.  Letter: Physostigmine reversal of sedative drugs.

Authors:  H Rosenberg
Journal:  JAMA       Date:  1974-08-26       Impact factor: 56.272

6.  Reversal of antiparkinsonian drug toxicity by physostigmine: a controlled study.

Authors:  M K el-Yousef; D Janowsky; J M Davis; H J Sekerke
Journal:  Am J Psychiatry       Date:  1973-02       Impact factor: 18.112

7.  Tricyclic antidepressant poisoning. Reversal of coma, choreoathetosis, and myoclonus by physostigmine.

Authors:  J S Burks; J E Walker; B H Rumack; J E Ott
Journal:  JAMA       Date:  1974-12-04       Impact factor: 56.272

8.  Anticholinergic poisoning: treatment with physostigmine.

Authors:  B H Rumack
Journal:  Pediatrics       Date:  1973-09       Impact factor: 7.124

9.  Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs.

Authors:  R P Granacher; R J Baldessarini
Journal:  Arch Gen Psychiatry       Date:  1975-03

10.  Brain receptors for antipsychotic drugs and dopamine: direct binding assays.

Authors:  P Seeman; M Chau-Wong; J Tedesco; K Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205
View more
  4 in total

1.  Adverse effects of physostigmine.

Authors:  A Houghton
Journal:  Can Anaesth Soc J       Date:  1977-07

2.  A randomized evaluation of the reversal of ketamine by physostigmine.

Authors:  J C Drummond; J Brebner; S Galloon; P S Young
Journal:  Can Anaesth Soc J       Date:  1979-07

3.  Physostigmine reversal of postoperative somnolence.

Authors:  G E Hill; T H Stanley; C R Sentker
Journal:  Can Anaesth Soc J       Date:  1977-11

Review 4.  Postoperative opisthotonus and torticollis after fentanyl, enflurane, and nitrous oxide.

Authors:  D J Dehring; B Gupta; W T Peruzzi
Journal:  Can J Anaesth       Date:  1991-10       Impact factor: 5.063
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.